Your browser doesn't support javascript.
loading
Safety study of Ciprofloxacin in newborn mice.
Bourgeois, Thomas; Delezoide, Anne-Lise; Zhao, Wei; Guimiot, Fabien; Adle-Biassette, Homa; Durand, Estelle; Ringot, Maud; Gallego, Jorge; Storme, Thomas; Le Guellec, Chantal; Kassaï, Behrouz; Turner, Mark A; Jacqz-Aigrain, Evelyne; Matrot, Boris.
Afiliação
  • Bourgeois T; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France.
  • Delezoide AL; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Department of Developmental Biology, Robert Debré Hospital, APHP, Paris, France.
  • Zhao W; Inserm, Clinical Investigation Center CIC 1426, Robert Debré Hospital, APHP, Paris, France; Department of Pediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, APHP, Paris, France.
  • Guimiot F; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Department of Developmental Biology, Robert Debré Hospital, APHP, Paris, France.
  • Adle-Biassette H; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Department of Pathology, Lariboisière Hospital, APHP, 75010, Paris, France.
  • Durand E; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; PhenoPups SAS, Evry, France.
  • Ringot M; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France.
  • Gallego J; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France.
  • Storme T; Department of Pharmacy, Robert Debré Hospital, APHP, Paris, France.
  • Le Guellec C; EA4245, Faculté de Médecine, Université François Rabelais, Tours, France.
  • Kassaï B; Department of Clinical Pharmacology and Clinical Trials, Louis Pradel Hospital, EPICIME, Lyon, France; CNRS, UMR, 5558, Lyon, France; Lyon-1 University, Lyon, France; Inserm, Clinical Investigation Center CIC1407, Louis Pradel Hospital, Lyon, France.
  • Turner MA; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Jacqz-Aigrain E; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France; Inserm, Clinical Investigation Center CIC 1426, Robert Debré Hospital, APHP, Paris, France; Department of Pediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, APHP, Paris, France.
  • Matrot B; Inserm, U1141, Robert Debré Hospital, APHP, 75019, Paris, France; Denis Diderot-Paris 7 University, Robert Debré Hospital, Paris, France. Electronic address: boris.matrot@inserm.fr.
Regul Toxicol Pharmacol ; 74: 161-9, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26627140
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciprofloxacina / Antibacterianos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciprofloxacina / Antibacterianos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França